Selective gene transfer to tumor cells by recombinant Newcastle Disease Virus via a bispecific fusion protein
/in International Publications, Newcastle Disease Virus /von 2005-02-01 / Int. J. Oncol. 2005 Feb;26(2):431-9Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination
/in Breast Cancer, Dendritic Cells, International Publications /von 2005-02-01 / Scand. J. Immunol. 2005 Feb;61(2):147-56A thermometry system for quality assurance and documentation of whole body hyperthermia procedures
/in Hyperthermia, International Publications /von 2005-02-01 / Int J Hyperthermia 2005 Feb;21(1):45-55Effects of dendritic cells transfected with full length wild-type p53 and modified by bile duct cancer lysates on immune response
/in Gallbladder Cancer, International Publications /von 2005-02-01 / HBPD INT 2005 Feb;4(1):121-5
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution